What is Repare Therapeutics Inc (RPTX) stock price today?

Repare Therapeutics Inc (RPTX) currently trades at $2.65 per share. The stock has a market capitalization of $114.24M and a P/E ratio of —x.

Is RPTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Repare Therapeutics Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Repare Therapeutics Inc's revenue and earnings?

Repare Therapeutics Inc has trailing twelve-month (TTM) revenue of $11.87M with profit margins of 0.00%. Earnings per share (EPS) is $-1.70.

RPTX

Repare Therapeutics Inc

NASDAQ: RPTX · HEALTHCARE · BIOTECHNOLOGY

$2.65

+0.00% today

Updated 2026-01-28

Market cap

$114.24M

P/E ratio

—

P/S ratio

9.62x

EPS (TTM)

$-1.70

Dividend yield

—

52W range

$1 – $3

Volume

1.4M

Market cap

$114.24M

P/E ratio

—

P/S ratio

9.62x

EPS (TTM)

$-1.70

Dividend yield

—

52W range

$1 – $3

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$3.00

+13.21%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $2.65M — positive

Risks

- Thin margins at 0.00%

- Revenue declining -0.77% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$7.60M	$131.83M	$51.13M	$53.48M	$11.87M
Net income	$-106.91M	$-29.05M	$-93.80M	$-84.69M	$3.26M
EPS	—	—	—	—	$-1.70
Free cash flow	$-87.49M	$-280000.00	$-129.10M	$-76.44M	$2.65M
Profit margin	-1,406.68%	-22.03%	-183.44%	-158.37%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RPTX	$114.24M	27	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Repare Therapeutics Inc trades at $2.65. Our Smart Value Score of 27/100 indicates the stock is weak. TTM revenue stands at $11.87M.

Frequently asked questions

What is Repare Therapeutics Inc's stock price?

Repare Therapeutics Inc (RPTX) trades at $2.65.

Is Repare Therapeutics Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Repare Therapeutics Inc (RPTX)?

The analyst target price is $3.00, representing +13.2% upside from the current price of $2.65.

What is Repare Therapeutics Inc's revenue?

TTM revenue is $11.87M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio9.62x

ROE-0.50%

Beta0.96

50D MA$2.38

200D MA$1.79

Shares out0.04B

Float0.02B

Short ratio—

Avg volume1.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RPTX vs LLY →RPTX vs JNJ →RPTX vs ABBV →Stock screener →